A virus causing respiratory tract illness in susceptible mammals

Details for Australian Patent Application No. 2002228471 (hide)

Owner Vironovative B.V.

Inventors Van Den Hoogen, Bernadetta, Gerarda; De Jong, Jan, Cornelius; Fouchier, Ronaldus, Adrianus, Maria; Groen, Jan; Osterhaus, Albertus, Dominicus, Marcellinus, Erasmus

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002228471

PCT Pub. Number WO2002/057302

Priority 01203985.5 18.10.01 EP; 01200213.5 19.01.01 EP

Filing date 18 January 2002

Wipo publication date 30 July 2002

Acceptance publication date 14 February 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 35/64 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002228471

14 February 2008 Application Accepted

  Published as AU-B-2002228471

12 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228472-Dispersing agent

2002228470-CLONING AND EXPRESSION OF A NEW MCP RECEPTOR IN GLIAL CELLS